FDG-PET/CT can predict distant metastasis and survival in hypopharyngeal squamous cell carcinoma: Study

Published On 2022-05-21 05:00 GMT   |   Update On 2022-05-21 09:12 GMT

Japan: 18F-FDG-PET/CT is helpful for predicting distant metastasis, overall survival, and distant metastasis-free survival in patients with hypopharyngeal squamous cell carcinoma (HPSCC), a recent study has stated. The study appears in the Journal of Otolaryngology - Head & Neck Surgery. "The study highlights the role of SUVmax in pretreatment primary tumors of HPSCC and shows...

Login or Register to read the full article

Japan: 18F-FDG-PET/CT is helpful for predicting distant metastasis, overall survival, and distant metastasis-free survival in patients with hypopharyngeal squamous cell carcinoma (HPSCC), a recent study has stated. The study appears in the Journal of Otolaryngology - Head & Neck Surgery. 

"The study highlights the role of SUVmax in pretreatment primary tumors of HPSCC and shows that SUVmax is significantly associated with overall survival, distant metastasis-free survival, and distant metastasis," Shinsuke Suzuki, Department of Otorhinolaryngology and Head and Neck Surgery, Akita University Graduate School of Medicine, Akita, Japan, and colleagues wrote in their study. 

 A high rate of distant metastasis in hypopharyngeal squamous cell carcinoma results in poor prognosis. In the study, the researchers team aimed to investigate the use of standardized uptake value (SUVmax), which was assessed via pretreatment 18-fluorodeoxyglucose positron emission tomography (FDG-PET), and computed tomography (CT) as prognostic factor, including its ability to predict distant metastases in patients with HPSCC.

For the purpose, 121 patients who underwent pretreatment FDG-PET/CT scanning and subsequent HPSCC treatment were included. SUVmax measurement was done via FDG-PET/CT. To determine whether the SUVmax was a predictor of distant metastasis and to select the best cutoff value, a receiver operating characteristic (ROC) curve analysis was used. The associations between SUVmax and other clinicopathological factors with distant metastasis-free survival were identified using univariate and multivariate Cox hazard regression analyses. 

The study led to the following findings:

· Distant metastases were identified in 33 patients during the median follow-up of 24 months after treatment.

· The ROC curve analysis determined that SUVmax was predictive of distant metastasis and identified a SUVmax of 13.9 as the best potential cutoff value.

· The univariate analysis showed that T and N classification, clinical stage, and SUVmax were significantly related to distant metastasis.

· In multivariate analysis, an SUVmax ≥ 13.9 was the only independent predictor of distant metastasis.

· Patients with high SUVmax values displayed significantly shorter distant metastasis-free survival and overall survival.

The authors conclude, "SUVmax determined via pretreatment FDG-PET/CT is useful for predicting distant metastasis, distant metastasis-free survival, and overall survival in patients with HPSCC."

Reference:

Suzuki, S., Toyoma, S., Abe, T. et al. 18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma. J of Otolaryngol - Head & Neck Surg 51, 13 (2022). https://doi.org/10.1186/s40463-022-00568-8

Tags:    
Advertisement
Article Source : Journal of Otolaryngology - Head & Neck Surgery

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News